250 search results for: Burden of Disease

Epidemiology and Pathophysiology <b>of</b> AD in Children
Dermatology
Epidemiology and Pathophysiology of AD in Children
expert video

In this expert interview video focusing on topics from the October 2024 ADVENT symposium at EAPS in Vienna, Austria, Dr Christine Bangert discusses the epidemiology of AD in children and the role of type 2 cytokines in driving the pathophysiology of the disease

View more
Atopic and Nonatopic Comorbidities in AD and the Importance <b>of</b> Early Intervention
Dermatology
Atopic and Nonatopic Comorbidities in AD and the Importance of Early Intervention
expert video

In this soundbite video from the April 2025 ADVENT Forum in Lisbon, Portugal, Dr Amy Paller reviews the increased risk of atopic and nonatopic comorbidities associated with atopic dermatitis and discusses the potential of early intervention to mitigate their development.

View more
GUF PNG
On Demand
Translating the Science of CSU: From Pathogenesis to Patient Outcomes

Watch as Drs. Michihiro Hide, Marta Ferrrer, and Ana M. Giménez-Arnau discuss chronic spontaneous urticaria (CSU) and highlight the unmet needs, importance of disease control, and emerging therapies.

UEG Upcoming Events Carousel Thumbnail
On Demand
Bridging the Gap in EoE: Innovative Strategies for Seamless Transition of Care

Join leading experts in EoE, Thomas Greuter, MD, Edoardo Vincenzo Savarino, MD, PhD, and Carla Giordano, MD, PhD, as they use a case-based approach to explore the impact of chronic type 2 inflammation in EoE and outline strategies for optimizing transition of care and monitoring disease progression. They review the latest clinical evidence on therapeutic management and share insights from their own practice to support shared decision-making in the long-term care of EoE.

ADVENT at ERS 2024
On Demand
ERS 2024 | Targeting IL-33 in COPD: Exploring New Frontiers for COPD Management

Engage with experts Klaus Rabe, Stephanie Christenson, and Paola Rogliani in an educational symposium to explore the inflammatory pathways and phenotypes of COPD, investigate the genetic associations of IL-33 and COPD, examine early preclinical findings, and review ongoing research on the role of IL-33 in COPD.

What Is The COPD Vicious Cycle?
Pulmonology
What Is The COPD Vicious Cycle?
expert video

Dr. Nicola Hanania explains the vicious cycle of exacerbations and lung function decline observed in COPD.

View more
Master Clinician Video | The Moment <b>of</b> Impact: EoE in the Emergency Department (Chapter 1)
Gastroenterology
Master Clinician Video | The Moment of Impact: EoE in the Emergency Department (Chapter 1)
videoanimation

This chapter highlights how a food bolus impaction may be the initial manifestation of a patient with EoE masked by adaptive eating behavior.

View more
Expert Interview with Dr Jason Hawkes
Dermatology
Expert Interview with Dr Jason Hawkes
expert video

Join Dr. Hawkes as he discusses what burdens and challenges CSU patients might expect and help identify that there are immune functions responsible for their symptoms not an external cause.

View more
What Differentiates COPD Exacerbations From Asthma Exacerbations?
Pulmonology
What Differentiates COPD Exacerbations From Asthma Exacerbations?
expert video

Join global expert Dr. Eric Bateman as he discusses how exacerbations in patients with COPD are different than exacerbations in patients with asthma.

View more
Assessing EoE: Measuring Quality <b>of</b> Life in Patients With EoE
Gastroenterology
Assessing EoE: Measuring Quality of Life in Patients With EoE
expert video

Join Dr. Nirmala Gonsalves as she reviews some of the tools to assess quality-of-life outcomes in patients with EoE.

View more
Gap in Care Leads to Progression <b>of</b> Fibrosis in EoE
Gastroenterology
Gap in Care Leads to Progression of Fibrosis in EoE
expert video

Dr. Evan Dellon discusses the clinical implications of gaps in medical care on the risk of fibrotic progression in EoE.

View more
What proportion <b>of</b> patients can achieve control in CRSwNP?
Rhinology
What proportion of patients can achieve control in CRSwNP?
expert video

Join Prof. Hellings and Prof. Corso in dicussion on the factors affecting complete control of CRSwNP, including treatment types, comorbidities, and the need for more data on biologics.

View more